Sevelamer Carbonate Powder, For Suspension
Product Images NDC 0955-1052
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 0955-1052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Sevelamer 02)
Figure 3 (Sevelamer 03)
Figure 4 (Sevelamer 04)
Principal Display Panel (800 mg Bottle Label)
Principal Display Panel (0.8 g Packet Box)
Principal Display Panel (2.4 g Packet Box)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.